Saberio Lo Presti,Tarec K Elajami,Reza Reyaldeen et al.
Saberio Lo Presti et al.
Recurrent pericarditis is associated with significant morbidity and adverse impact on quality of life. Contemporary studies have emphasized the key role of autoinflammatory pathways in its pathophysiology, mainly through the activation of i...
Sodium-glucose Cotransporter 2 Inhibitors' Rise to the Backbone of Heart Failure Management: A Clinical Review [0.03%]
钠-葡萄糖共转运蛋白2抑制剂在心力衰竭治疗中的崛起：临床综述
Namit Rohant,Jamie Lw Kennedy
Namit Rohant
Sodium-glucose cotransporter (SGLT) 2 inhibitors, or gliflozins, have quickly risen to prominence within the cardiovascular field due to their substantial benefit in the management of heart failure with reduced ejection fraction (HFrEF). SG...
Michael J Reardon
Michael J Reardon
Based on the strength of data from randomized trials and real-world clinical studies, transcatheter aortic valve replacement (TAVR) has become a popular and effective alternative to surgical valve replacement in patients with symptomatic ao...
Comprehensive Review of Complete Versus Culprit-only Revascularization for Multivessel Disease in ST-segment Elevation Myocardial Infarction [0.03%]
ST段抬高型心肌梗死多支病变冠脉全面血运重建与单纯罪犯血管介入治疗的系统评价和 meta 分析
Robin Jacob,Ayaaz K Sachedina,Sachin Kumar
Robin Jacob
Several organizations have developed guidelines for the management of ST-segment elevation myocardial infarction (STEMI). However, the optimal strategy regarding revascularization in the setting of multivessel disease, specifically with reg...
Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease [0.03%]
外周动脉疾病患者主要以动脉粥样硬化血栓形成事件的二级预防为主的药物治疗
Justin T Morrison,Judith Hsia,Marc P Bonaca
Justin T Morrison
Patients with peripheral artery disease (PAD) are at risk for severe morbidity and mortality, including ischaemic-related events. Furthermore, there is heterogeneity within the PAD population, where the drivers of risk for cardiovascular an...
Clifton Espinoza,Debabrata Mukherjee
Clifton Espinoza
Coronary artery disease (CAD) is prevalent throughout the world, with a significant impact on global health. There is a vast collection of data in the medical literature relating to the topic of dual antiplatelet therapy (DAPT) in patients ...
Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions [0.03%]
恶化的心力衰竭的门诊管理：现策略与未来方向
Alison L Wand,Stuart D Russell,Nisha A Gilotra
Alison L Wand
Heart failure (HF) is a highly prevalent and morbid disease in the USA. The chronic, progressive course of HF is defined by periodic exacerbations of symptoms, described as 'worsening heart failure' (WHF). Previously, episodes of WHF have r...
Left Main Stenosis Stenting Normalises Wall Shear Stress of Ascending Aorta in Bicuspid Aortic Valve [0.03%]
左主干狭窄支架植入可使二叶式主动脉瓣升主动脉壁剪切应力正常化
Gianluca Rigatelli,Marco Zuin
Gianluca Rigatelli
Introduction: Bicuspid aortic valve (BAV) is associated with dilation and dissection of the ascending aorta. The high shear forces within the ascending aorta lumen seem to have a pivotal role on the development of such co...
The Quantification of Total Coronary Atheroma Burden - A Major Step Forward [0.03%]
冠脉斑块负担量化——重大突破一步前行
Jean-Marc Foult,Shruthi Pranesh,Matthew J Budoff
Jean-Marc Foult
The extent of coronary artery disease has been shown to be an important indicator of prognosis. Cardiac computed tomography (CT) has the ability to measure plaque, with both coronary artery calcium scanning and CT angiography (CTA), to give...
The Myval Transcatheter Heart Valve System for the Treatment of Severe Aortic Stenosis - Current Evidence and Future Directions [0.03%]
Myval经导管主动脉瓣系统治疗严重主动脉瓣狭窄的当前证据和未来方向
Gunasekaran Sengottuvelu,Vijay Kumar,Ashok Seth
Gunasekaran Sengottuvelu
Transcatheter aortic valve replacement has revolutionised the treatment of aortic valve disease. The Myval™ device (Meril Life Sciences Pvt. Ltd., Gujarat, India) is a CE-marked, next-generation balloon-expandable transcatheter heart valve...